Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 430 in its research report dated November 14, 2022. Read More Top 100 Best Sellers
Prabhudas Lilladher is bullish on Ashok Leyland has recommended buy rating on the stock with a target price of Rs 200 in its research report dated November 14, 2022. Top 100 Best Sellers Read More
Prabhudas Lilladher is bullish on Apollo Hospitals Enterprise has recommended buy rating on the stock with a target price of Rs 5400 in its research report dated November 14, 2022. Top 100 Best Sellers Read More
Prabhudas Lilladher is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 163 in its research report dated November 11, 2022. Top 100 Best Sellers Read More
Prabhudas Lilladher is bullish on Zee Entertainment Enterprises has recommended buy rating on the stock with a target price of Rs 308 in its research report dated November 12, 2022. Top 100 Best Sellers Read More
Prabhudas Lilladher is bullish on Oil India has recommended buy rating on the stock with a target price of Rs 300 in its research report dated November 11, 2022. Read More Top 100 Best Sellers
Prabhudas Lilladher is bullish on Muthoot Finance has recommended buy rating on the stock with a target price of Rs 1431 in its research report dated November 11, 2022. Read More Top 100 Best Sellers
Prabhudas Lilladher is bullish on Eicher Motors has recommended buy rating on the stock with a target price of Rs 4190 in its research report dated November 11, 2022. Read More Top 100 Best Sellers
In today’s edition of Moneycontrol Pro Panorama: Pricing of off-patent drugs is not the solution, personal investment is like a running a marathon, days of ‘jumbo’ rate hikes might be over, and more Top 100 Best Sellers Read More
NULL Read More Top 100 Best Sellers
English 
हिन्दी